1-182573716-G-C

Variant summary

Our verdict is . The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_021133.4(RNASEL):​c.*1676C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.262 in 182,562 control chromosomes in the GnomAD database, including 6,760 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 5633 hom., cov: 33)
Exomes 𝑓: 0.26 ( 1127 hom. )

Consequence

RNASEL
NM_021133.4 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0980

Publications

12 publications found
Variant links:
Genes affected
RNASEL (HGNC:10050): (ribonuclease L) This gene encodes a component of the interferon-regulated 2-5A system that functions in the antiviral and antiproliferative roles of interferons. The protein is involved in innate immunity and is active against multiple RNA viruses, including the influenza and SARS-CoV-2 viruses. Mutations in this gene have been associated with predisposition to prostate cancer and this gene is a candidate for the hereditary prostate cancer 1 (HPC1) allele. [provided by RefSeq, Nov 2021]
RNASEL Gene-Disease associations (from GenCC):
  • multisystem inflammatory syndrome in children and adults
    Inheritance: AR Classification: MODERATE Submitted by: PanelApp Australia
  • prostate cancer, hereditary, 1
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_021133.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.367 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021133.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RNASEL
NM_021133.4
MANE Select
c.*1676C>G
3_prime_UTR
Exon 7 of 7NP_066956.1Q05823-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RNASEL
ENST00000367559.7
TSL:1 MANE Select
c.*1676C>G
3_prime_UTR
Exon 7 of 7ENSP00000356530.3Q05823-1
RNASEL
ENST00000946546.1
c.*1676C>G
3_prime_UTR
Exon 7 of 7ENSP00000616605.1
RNASEL
ENST00000890859.1
c.*1676C>G
3_prime_UTR
Exon 7 of 7ENSP00000560918.1

Frequencies

GnomAD3 genomes
AF:
0.262
AC:
39778
AN:
152040
Hom.:
5629
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.191
Gnomad AMI
AF:
0.427
Gnomad AMR
AF:
0.345
Gnomad ASJ
AF:
0.374
Gnomad EAS
AF:
0.186
Gnomad SAS
AF:
0.382
Gnomad FIN
AF:
0.192
Gnomad MID
AF:
0.411
Gnomad NFE
AF:
0.285
Gnomad OTH
AF:
0.273
GnomAD4 exome
AF:
0.265
AC:
8045
AN:
30404
Hom.:
1127
Cov.:
0
AF XY:
0.270
AC XY:
3788
AN XY:
14010
show subpopulations
African (AFR)
AF:
0.187
AC:
205
AN:
1094
American (AMR)
AF:
0.315
AC:
227
AN:
720
Ashkenazi Jewish (ASJ)
AF:
0.354
AC:
691
AN:
1952
East Asian (EAS)
AF:
0.171
AC:
1018
AN:
5950
South Asian (SAS)
AF:
0.372
AC:
99
AN:
266
European-Finnish (FIN)
AF:
0.357
AC:
5
AN:
14
Middle Eastern (MID)
AF:
0.354
AC:
68
AN:
192
European-Non Finnish (NFE)
AF:
0.284
AC:
5040
AN:
17776
Other (OTH)
AF:
0.284
AC:
692
AN:
2440
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
258
517
775
1034
1292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.262
AC:
39794
AN:
152158
Hom.:
5633
Cov.:
33
AF XY:
0.262
AC XY:
19474
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.191
AC:
7927
AN:
41498
American (AMR)
AF:
0.345
AC:
5279
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.374
AC:
1298
AN:
3466
East Asian (EAS)
AF:
0.185
AC:
958
AN:
5178
South Asian (SAS)
AF:
0.382
AC:
1841
AN:
4822
European-Finnish (FIN)
AF:
0.192
AC:
2033
AN:
10602
Middle Eastern (MID)
AF:
0.422
AC:
124
AN:
294
European-Non Finnish (NFE)
AF:
0.285
AC:
19362
AN:
67980
Other (OTH)
AF:
0.276
AC:
583
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1526
3051
4577
6102
7628
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
408
816
1224
1632
2040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.153
Hom.:
284
Bravo
AF:
0.268
Asia WGS
AF:
0.297
AC:
1032
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
5.5
DANN
Benign
0.75
PhyloP100
0.098
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.